New capital, maturing pipelines, and a more global R&D mindset are pushing valuations higher, even as competition tightens.

Shares of Chinese biotechnology company Nanjing Leads Biolabs surged in their Hong Kong debut after overwhelming demand from investors. Shares surged as much as 127% to 79.60 Hong Kong dollars, ...

The dollar gained against the yen after bouncing off a two-week low on Thursday, helped by some firm US economic data, while ...

HONG KONG -- A price war has broken out in the Hong Kong financial world as competition among investment banks drives down underwriting fees for initial public offerings in what has become the world's ...

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company") listed on the Main Board of The Stock Exchange of Hong Kong Limited (HKEX) under the stock code "09887".

The U.S. House Select Committee on China subpoenaed JPMorgan Chase CEO Jamie Dimon and Bank of America CEO Brian Moynihan ...

An announcement from Masonglory Limited ( ($MSGY) ) is now available. On July 24, 2025, Masonglory Limited announced the ...

Masonglory Limited (the “Company” or “MSGY”), a Hong Kong based subcontractor providing wet trades and related ancillary services to private and public sectors, today announced that it closed the sale ...

Cre8 Enterprise Limited (Nasdaq: CRE) (the "Company"), a Hong Kong-based integrated financial printing service provider, today announced the closing of its ...

Hillhouse Frontier Holdings is producing declining revenues and shrinking gross profits from a small revenue base. Click here ...

We believe the move by firms like China Renaissance into crypto is, in a word, inevitable. Crypto is no longer a back-alley ...

The controversy over Robinhood’s OpenAI private stock tokens is only the beginning of a wider legal battle over tokenized equities.